The Open University - Medicating the bottom billion

Published on
April 9, 2009
Last updated
May 22, 2015

The Open University played host to a debate about the huge sums spent on the fight against Aids and other killer conditions in developing countries. Discussion at the two-day meeting in Milton Keynes revolved around integrating foreign investment into healthcare and drug production in the world's poorest countries. Joanna Chataway, co-director of the Innogen Centre, which investigates shared ground in the fields of biotechnology and genomics, said the funding balance was not yet right. "In developing new drugs, there is a need to resolve capacity within developing countries so that they not only have access to these medicines, but they are capable of contributing to the production and distribution of them," she said.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please
or
to read this article.

Sponsored

Featured jobs

See all jobs
ADVERTISEMENT